peptide mapping is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-04-08. Where a claim depends on a specific study, the study is described rather than over-claimed.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.
The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.
| Property | Value | Notes |
|---|---|---|
| Analytical method | LC-MS/MS | Preferred confirmatory technique |
| Appearance | White to off-white powder | Lyophilised form |
| Solubility | Freely soluble in water | Also described in saline |
| Storage temperature | Below -20 °C for powder | Short-term refrigeration for solutions |
| Regulatory status | Prohibited in sport | Listed under peptide hormones |
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
==== Prewar theory ==== Prewar doctrine was based on the idea "the bomber will always get through". Despite RAF and Luftwaffe experience with daylight bombing, the USAAF still incorrectly believed in 1942 that tightly packed formations of bombers would have so much firepower that they could fend off fighters on their own. Fighter escort was a low priority, but when the concept was discussed in 1941, the Lockheed P-38 Lightning was considered to be most appropriate, as it had the speed and range. Another school of thought favored a heavily up-armed "gunship" conversion of a strategic bomber. A single-engined, high-speed fighter with the range of a bomber was thought to be an engineering impossibility.
==== MeSH D12.125.072 – amino acids, cyclic ==== MeSH D12.125.072.050 – amino acids, aromatic MeSH D12.125.072.050.342 – dextrothyroxine MeSH D12.125.072.050.685 – phenylalanine MeSH D12.125.072.050.685.400 – dihydroxyphenylalanine MeSH D12.125.072.050.685.400.180 – cysteinyldopa MeSH D12.125.072.050.685.400.500 – levodopa MeSH D12.125.072.050.685.400.600 – methyldopa MeSH D12.125.072.050.685.440 – fenclonine MeSH D12.125.072.050.685.450 – p-fluorophenylalanine MeSH D12.125.072.050.685.500 – melphalan MeSH D12.125.072.050.767 – thyroxine MeSH D12.125.072.050.767.741 – thyronines MeSH D12.125.072.050.767.741.180 – diiodothyronines MeSH D12.125.072.050.767.741.894 – triiodothyronine MeSH D12.125.072.050.767.741.947 – triiodothyronine, reverse MeSH D12.125.072.050.850 – tryptophan MeSH D12.125.072.050.850.479 – 5-hydroxytryptophan MeSH D12.125.072.050.875 – tyrosine MeSH D12.125.072.050.875.064 – betalains MeSH D12.125.072.050.875.064.500 – betacyanins MeSH D12.125.072.050.875.130 – dihydroxyphenylalanine MeSH D12.125.072.050.875.130.180 – cysteinyldopa MeSH D12.125.072.050.875.130.500 – levodopa MeSH D12.125.072.050.875.130.600 – methyldopa MeSH D12.125.072.050.875.262 – diiodotyrosine MeSH D12.125.072.050.875.379 – melanins MeSH D12.125.072.050.875.496 – monoiodotyrosine MeSH D12.125.072.050.875.664 – methyltyrosines MeSH D12.125.072.050.875.664.050 – alpha-methyltyrosine MeSH D12.125.072.050.875.750 – phosphotyrosine MeSH D12.125.072.170 – cycloleucine MeSH D12.125.072.200 – desmosine MeSH D12.125.072.329 – histidine MeSH D12.125.072.329.269 – ergothioneine MeSH D12.125.072.329.539 – methylhistidines MeSH D12.125.072.401 – imino acids MeSH D12.125.072.401.200 – azetidinecarboxylic acid MeSH D12.125.072.401.623 – proline MeSH D12.125.072.401.623.270 – captopril MeSH D12.125.072.401.623.374 – fosinopril MeSH D12.125.072.401.623.478 – hydroxyproline MeSH D12.125.072.401.761 – pyrrolidonecarboxylic acid MeSH D12.125.072.401.830 – technetium tc 99m diethyl-iminodiacetic acid MeSH D12.125.072.401.840 – technetium tc 99m disofenin MeSH D12.125.072.401.900 – technetium tc 99m lidofenin MeSH D12.125.072.415 – isodesmosine
posttraumatic osteoarthritis As mentioned, damage to the chondral surface of the joint has a high risk of posttraumatic arthritis if the joint is not returned to native alignment. malunion When bones are not set back into close to native alignment there is a risk of healing in a malformed position. nonunion If there is not adequate blood flow to provide healing factors to the fracture or there is too much movement at the area of injury there is risk of not healing. Diabetes, smoking, and peripheral vascular disease increase risk of nonunion. avascular necrosis When fractured, blood supply can be disrupted to certain bones or areas of bone causing that portion of bone to die and necrose. Examples include the femoral head of the hip joint and the scaphoid of the wrist. joint stiffness and pain Damaged soft tissue leads to build up of scar tissue which can make joints stiff and painful.
Sources: en.wikipedia.org
Ferdinand II 1564–1595, second son of Emperor Ferdinand I Maximilian III 1612–1618, son Leopold V 1619–1632, younger brother of Emperor Ferdinand II Ferdinand Charles 1632–1662, son, with his mother Claudia de' Medici 1632–1646, as regent Sigismund Francis 1663–1665, brother Line extinct, Habsburg lands re-unified under
== Animal requirements == All vertebrate and chordate species require vitamin A, either as dietary carotenoids or preformed retinol from consuming other animals. Deficiencies have been reported in laboratory-raised and pet dogs, cats, birds, reptiles and amphibians, also commercially raised chickens and turkeys. Herbivore species such as horses, cattle and sheep can get sufficient β-carotene from green pasture to be healthy, but the content in pasture grass dry due to drought and long-stored hay can be too low, leading to vitamin A deficiency. Omnivore and carnivore species, especially those toward the top of the food chain, can accrue large amounts of retinyl esters in their livers, or else excrete retinyl esters in urine as a means of dealing with surplus. Before the era of synthetic retinol, cod liver oil, high in vitamins A and D, was a commonly consumed dietary supplement. Invertebrates cannot synthesize carotenoids or retinol, and thus must accrue these essential nutrients from consumption of algae, plants or animals.
In contrast, the French financial system was inadequate and Napoleon's forces had to rely in part on requisitions from conquered lands. From London in 1813 to 1815, Nathan Mayer Rothschild was crucial in almost single-handedly financing the British war effort, organising the shipment of bullion to the Duke of Wellington's armies across Europe, as well as arranging the payment of British financial subsidies to their continental allies.
Sources: en.wikipedia.org
The most common approach is liquid chromatography with tandem mass spectrometry after extraction from blood or urine. Immunoassays exist but are generally treated as screening tools because of cross-reactivity.
Dry lyophilised powder is normally kept frozen and protected from moisture and light. Dissolved material is handled cold and used promptly to limit degradation.
It is not licensed as a medicine in major markets and is distributed as a research chemical. Sports organisations prohibit its use, and some countries restrict import and supply.
Divide it into single-use aliquots and hold them frozen at -20 °C or below, protected from light. Repeated thawing of one container is the main avoidable source of variability.